We are concerned with the problem of estimating the treatment effects at the effective doses in a dose-finding study. Under monotone dose-response, the effective doses can be identified through the estimation of the minimum effective dose, for which there is an extensive set of statistical tools. In particular, when a fixed-sequence multiple testing procedure is used to estimate the minimum effective dose, Hsu and Berger (1999) show that the confidence lower bounds for the treatment effects can be constructed without the need to adjust for multiplicity. Their method, called the dose-response method, is simple to use, but does not account for the magnitude of the observed treatment effects. As a result, the dose-response method will estimate the treatment effects at effective doses with confidence bounds invariably identical to the hypothesized value. In this paper, we propose an error-splitting method as a variant of the dose-response method to construct confidence bounds at the identified effective doses after a fixed-sequence multiple testing procedure. Our proposed method has the virtue of simplicity as in the dose-response method, preserves the nominal coverage probability, and provides sharper bounds than the dose-response method in most cases.
Introduction
In early stage of drug development, a primary scientific objective is to identify doses that exhibit adequate drug activity, indicated by a shift of mean response from the control group by a margin greater than a practically significant value d.
When the dose-response is monotone increasing, the effective doses can be identified through the estimation of the minimum effective dose. At the same time, for the purposes of planning future experiments, it is also important to precisely assess the effect size at the identified effective doses. There is a long history and large literature on the estimation of minimum effective dose, including single-step procedures such as Bonferroni's adjustment and Dunnett's (1955) procedure for many-to-one comparisons, step-down methods due to Naik (1975) and Marcus et al. (1976) , and a variety of stepwise procedures described in Tamhane et al. (1996) .
On the other hand, relatively little attention has been given to the joint estimation of effective doses and their effect sizes. In fact, it has long been thought that stepwise procedures do not naturally yield confidence sets through inversion (Lehmann, 1986) until Bofinger (1987) and Stefansson et al. (1988) who derive confidence bounds following a step-down test by partitioning principle. Subsequently, Hsu and Berger (1999) propose a dose-response method to find stepwise confidence bounds without multiplicity adjustment. A difficulty associated with these methods is that the confidence bounds for the treatment effects at the identified effective doses always equal the hypothesized value irrespective of the data. To illustrate, Table 1 extracts the dose-response data and the confidence bounds given in Hsu and Berger (1999) who consider d ¼ 7. The minimum effective dose is estimated to be dose 4 by the dose-response method of Hsu and Berger (1999) , and dose 5 by the confidence bounds of Stefansson et al. (1988) . The treatment effects at all identified effective doses are estimated with a confidence lower bound of d ¼ 7 by the dose-response method, despite the fact that the observed effect sizes at the higher doses (dose 5 and above) are apparently much larger than 7. In practice, if we use this lower bound (i.e. 7) as an assumed effect size in the planning of a future study, we will unduly require a much larger sample size than needed. The fundamental problem is that these procedures use up the error in the testing procedure to establish confidence direction (i.e. whether there is an effect of the dose) with no margin of error left for estimation of the effect size. In this paper, we propose a two-step procedure that ''splits the error rate'' in two parts respectively for testing and estimation, and apply this procedure to modify Hsu and Berger's dose-response method.
Methods
Consider the balanced one-way layout Y ij ¼ m i þE ij for i ¼ 0, . . . ,k and j ¼ 1, . . . ,n, where Y ij denotes the response of subject j in dose i, and E ij is a normal random noise with mean 0 and variance s 2 e . Let g i ¼ m i Àm 0 be the treatment effect of dose i relative to the control, which is commonly estimated by the pairwise statistic
e =n and corrðT i ,T j Þ ¼ r ¼ 1=2. In addition, under monotonicity, i.e., g 1 r Á Á Á rg k , the minimum effective dose n minfi : g i 4 dg is equal to maxfi : g i rdgþ1; we adopt the convention that minf|g ¼ k þ1 and maxf|g ¼ 0. Then the ð1ÀaÞ-upper confidence bound for n iŝ n a ¼ maxfi :
where z a denotes the upper a critical point of standard normal distribution. In general, the variance s 2 can be consistently estimated; here, it is assumed known for brevity. Ifn a Z 2, the dose-response method asserts that g i 4 d for all i Zn a and g^n a À1 4 Tn a À1 Àz a s. Whenn a ¼ 1, the stepwise confidence bound is g i 4 min i ¼ 1,...,k fT i Àz a sg for all i. The confidence bounds thus obtained will achieve a 100ð1ÀaÞ% coverage probability by Theorem 1 in Hsu and Berger (1999) when s 2 is assumed known.
To improve the precision of the confidence bounds at the effective doses while maintaining the same coverage probability, we propose to estimate n at a slightly more conservative significance level, i.e.,n at where a t ra. With this estimate of n, the confidence bounds for the effect sizes can be constructed as follows: Dose response data from Hsu and Berger (1999) , and 95% simultaneous lower confidence bounds on the treatment effects g i by the Hsu-Berger doseresponse method (HB), the error-splitting method, the partitioning principle by Stefansson et al. (1988, MPGN) , and Dunnett's (1955) where ðZ 1 ,Z 2 Þ 0 is distributed as bivariate normal with standard normal marginal and a correlation coefficient of 0.5 between Z 1 and Z 2 . Then, prfg 2 CðTÞg Z 1Àa.
The condition (2) in Proposition 1 provides some guidance on how the error probabilities, a t and a e , should be chosen. First, consider the case a t ¼ a, under which condition (2) imposes a e ¼ 0. In this case, the bound CðTÞ is identical to the confidence bound due to the Hsu-Berger dose-response method whenn a 4 1; however, it is easy to verify that the former is more conservative than the latter whenn a ¼ 1. Therefore, setting a t ¼ a is not an admissible choice.
Second, consider the case a t r a e oa so that z e r z t . Then condition (2) does not depend on a t . In other words, we can increase the test level a t without affecting the overall coverage probability, as long as a t ra e . A practical implication is that we should set a t to be at least as large as a e .
From now on , we will focus on a e ra t o a so thatn a rn at , under which it is possible for the error-splitting approach to yield a more conservative estimate of n than the Hsu-Berger dose-response method. The motivation, on the other hand, is to improve the confidence lower bounds at the estimated effective doses. When a t ¼ a e , the lower bound CðTÞ g i 4 maxðTn a t Àsz e ,dÞ ¼ maxðTn a t Àsz t ,dÞ 4 d
for the estimated effective doses, i.e., i Zn at , if 2rn a rn at r k. The last inequality in (3) is a result of the definition ofn at in
(1). If the true g i at the minimum effective dose is far greater than d, the gain over the dose-response method (which gives a lower bound of d) is potentially substantial. To preserve the gain for the general case a e ra t , the comparison (3) suggest choosing a value of a e that is not much smaller than a t ; see also the simulation results in Section 3. It is important to note that our proposed CðTÞ is not uniformly better than the Hsu-Berger dose-response method in terms of the lower bound. In particular, whenn a ¼n at ¼ 1, the lower bound CðTÞ gives g i 4maxðT 1 Àsz e ,dÞ for all i, whereas the dose-response method gives g i 4 min i ¼ 1,...,k fT i Àsz a g. Depending on the shape of the dose-response curve, the dose-response method can likely be superior to CðTÞ on the event fn a ¼n at ¼ 1g since the Hsu-Berger method does not require the monotonicity assumption.
Our discussion has been assuming a known s 2 e . In situations when the variance s 2 e is unknown, we could apply the error-splitting approach in an analogous manner by replacing s 2 e with the pooled sample variance, and using the critical values with respect to a t distribution with ðnÀ1Þðkþ 1Þ degrees of freedom. It is easy to see that this procedure will achieve the nominal coverage probability asymptotically. For small-to-moderate sample sizes, intuitively, this approach will be conservative because t distribution has a heavier tail than the normal distribution. In the simulation study that follows, we will implement this procedure and examine the performance of the error splitting procedure in finite sample settings.
Numerical studies
We first consider the dose response data in Hsu and Berger (1999) , who compared nine doses to a placebo with six subjects per dose level. The goal was to identify doses having a mean that is 7 mg/kg greater than that of the placebo, i.e., d ¼ 7. Table 1 shows the 95% confidence lower bounds given by the error-splitting method with a t ¼ 0:045,0:040,0:035, 0:030,0:025, with respective a e ¼ 0:008,0:014,0:020,0:026,0:025 so that overall a ¼ 0:05 in accord with condition (2). The results due to the Hsu-Berger dose-response method, the partitioning principle (Stefansson et al., 1988) , and Dunnett's (1955) method are also given. When a t is close to the nominal a, the error-splitting method behaves similarly to the doseresponse method, and selects dose 4 as the minimum effective dose. However, it does not materialize the advantage of our proposed method as a e is extremely small. When a t r 0:035, the error-splitting method estimates n with dose level 5 but provides a much more encouraging effect size at this dose (and above) than the dose-response method. The partitioning principle also estimates n with dose 5 but fails to use the observed data to estimate the effect size. In this example, Dunnett's method appears to be superior to the error-splitting approach. As we will see in the following simulation, Dunnett's method tends to yield sharper lower bounds on the higher doses but also tends to over-estimate n more often than the error-splitting approach.
Based on the dose-response data in Table 1 , we next simulated data from the normal distributions with a common standard deviation s e ¼ 7:8 at k¼ 9 doses with six subjects at each dose; we considered three sets of mean dose-response so that the true n ¼ 4. Table 2 gives the coverage probability (cov), the probability of selecting the true minimum effective dose (pcs), and the median of the lower bound at the truly effective doses based on 5000 simulation runs under each scenario. The coverage probability is estimated by the proportion when the lower bounds cover the true means of the nine doses simultaneously. Because the lower bounds may take values on negative infinity, we use medians (instead of means) of the lower bounds in the comparison.
As expected, the precision of CðTÞ improves for all g i 's with i 4n at as a t decreases and a e increases; on the other hand, we are slightly surprised to see non-trivial improvement even with small a e 's, namely when a t ¼ 0:040 and 0.045. Also as expected, the pcs tends to increase with a t . However, we find that its impact on the error-splitting approach is mild when compared to Dunnett's method. In general, the performance of the error-splitting approach is somewhere between Hsu-Berger dose-response method and Dunnett's method. Based on this simulation, setting a t ¼ 0:035 appears to strike a good balance between lower bound precision and pcs.
While the error-splitting procedure is asymptotically valid as long as the random error E ij has zero mean and finite variance, we examined its robustness in finite sample sizes in terms of coverage probability when the error distribution is non-normal. In particular, we performed additional simulations under the same sets of means with the errors generated from scaled t 3 and double exponential (DE) distributions with standard deviation s e ¼ 7:8. As indicated in Table 3 , the error-splitting approach achieves nominal coverage even when the sample size is as small as n¼6 per group.
We also examined the robustness of the error-splitting method under unequal sample sizes in the one-way layout. While Proposition 1 does not apply to these scenarios, the simulation results in Table 4 shows that mild imbalance in the one-way layout does not affect the coverage probability. It will indeed be interesting to extend our results to cover unbalanced one-way layout. Intuitively, we may extend Proposition 1 using the generalized Slepian's inequality for elliptically contoured distributions (Tong, 1980) , although the partitioning arguments used in the proof will require nontrivial manipulations, and warrant further investigation.
Proof of Proposition 1
Lemma. Let Y i , i ¼ 0, . . . ,n, n Z3, be independent real valued random variables and let Y i , i ¼ 1, . . . ,n, be identically distributed. Then
2 Bg,
¼ ðX 3 , . . . ,X n Þ 0 and B is a Borel set in the n À2-dimensional Euclidean space. cov, coverage probability; pcs, probability of selecting n; lbk, the median of lower bound of treatment effect at dose k, for k ¼ 4, . . . ,9.
Table 3
Coverage probability of the error-splitting method under non-normal data for given at. To prove Proposition 1, we define R i ¼ fReject H 0j for ir j r k; accept H 0,iÀ1 g, for i ¼ 1, . . . ,kþ 1, be the event of detecting dose i as the minimum effective dose in the testing procedure. In particular, R 1 ¼ fReject H 01 , . . . ,H 0k g ¼ fT i 4d þ sz t for all i 2 f1, . . . ,kgg, and R k þ 1 ¼ fAccept H 0k g ¼ fT k rd þ sz t g. Let CðTÞ denote the confidence bound for g ¼ ðg 1 , . . . ,g k Þ 0 generated by the error-splitting method based on T ¼ ðT 1 , . . . ,T k Þ 0 and C i ðTÞ denote the conference bound for g when the event R i occurs such that prfg 2 CðTÞg ¼ 
where the last equality is from (2).
For 1 ri rkÀ1 and i rj r k þ1, a j,i can be expressed as cov, coverage probability; pcs, probability of selecting n; lbk, the median of lower bound of treatment effect at dose k, for k ¼ 4, . . . ,9.
where A j c denotes the complement of A j . A set of the form A k \ Á Á Á \ A s is understood as O, the whole sample space, whenever s 4 k. We prove by induction that for any l such that i rl rkÀ1
g by the Lemma, hence (4) holds when l ¼ i, i 4kÀ1. Note that, when l ¼ i ¼ kÀ1, a kÀ1,kÀ1 ¼ prfB 0 k \ B kÀ1 g. Suppose (4) holds for l, we will prove that it also holds for l þ 1 rkÀ1. If lÀi is an even number, then
where the third inequality is by the Lemma. The case when lÀi is an odd number can be proved using the above technique and the fact that A where the first inequality follows from (4) and the last equality is by (2). The result can be proved similarly when kÀ1Ài is odd. &
